Alzheimer's Association Global Real-World Data Platforms (ALZ-RWD) Program supports teams developing and using patient data platforms to advance dementia research, care, and health equity.
The inquiry cutoff moves from January 1, 2026 to December 1, 2026. Full applications are now due February 2, 2027 at 5 p.m. ET, replacing the previously listed January 28 and February 2, 2026 deadlines; applications open December 1, 2026, and other details also changed.
Funder: Alzheimer's Association
Due Dates: Rolling (Pre-submission inquiries) | December 1, 2026 (Current-cycle inquiry cutoff and full applications open) | February 2, 2027, 5 p.m. ET (Full applications) | August 31, 2027 (Notification by)
Funding Amounts: USD $100,000–$1,000,000 per award for 12–24 months; direct costs only
Summary: Supports global real-world data platforms advancing Alzheimer's and dementia diagnosis, prevention, treatment, care, and health equity.
Key Information: Open to international (non-U.S.) applications; full applications are by invitation only, and GAAIN data sharing is required.
The Alzheimer's Association Global Real-World Data Platforms (ALZ-RWD) Program supports initiatives to develop, expand, use, and align real-world data platforms, including their infrastructure, data, and impact. Building on the Alzheimer's Network for Treatment and Diagnostics (ALZ-NET), it funds platforms housing patient health and health care information collected in real-world settings to advance Alzheimer's disease and other dementia research and care.
Supported activities include platform development and expansion, platform utilization, data collection, data integration and linking, and data analysis and publication. Other projects may also be considered. The program prioritizes harmonization and collaboration across global platforms, including ALZ-NET, and work with the potential to advance health equity, such as making platform populations representative of defined communities.